LUNG STAAR

Phase II Study of LUNG STereotactic Adaptive Ablative Radiotherapy for Central and Ultracentral Tumors (LUNG STAAR)

Study Name:
Phase II Study of LUNG STereotactic Adaptive Ablative Radiotherapy for Central and Ultracentral Tumors (LUNG STAAR)

Targeted Disease(s):
Lung Cancer

Purpose of Study:

The purpose of this research is to offer patients with centrally located early-stage non-small cell lung cancer (NSCLC) who are NOT candidates for surgery the opportunity to receive stereotactic body radiation therapy (SBRT).

Study Dates:
May 2, 2022 - October 1, 2032

Study Design:
Observational Design

Study Location:
Nationwide

Lead Institution:
Miami Cancer Institute at Baptist Health, Inc.

Funding Source:
View Ray Inc.

Contact:
Rupesh Kotecha, M.D.
Contact Phone: 786-596-2000
Contact Email: [email protected]

Sponsor:
Miami Cancer Institute at Baptist health, Inc.

Register for Trial
Asthma Educator Institute
, | Jul 11, 2022
Freedom From Smoking Clinic
Virtual, TX | Oct 18, 2022